ArticleDiagnostic and prognostic research2021
The Safety INdEx of Prehospital On Scene Triage (SINEPOST) study: the development and validation of a risk prediction model to support ambulance clinical transport decisions on-scene-a protocol.
Article in Diagnostic and prognostic research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 4 citations in OpenAlex.
- Ambulance quality and outcome measures for general non-conveyed populations (AQUA): A scoping review.PloS one · 2024Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 2 institutions in 1 country.
Funding
Abstract
backgroundDemand for both the ambulance service and the emergency department (ED) is rising every year and when this demand is excessive in both systems, ambulance crews queue at the ED waiting to hand patients over. Some transported ambulance patients are 'low-acuity' and do not require the treatment of the ED. However, paramedics can find it challenging to identify these patients accurately. Decision support tools have been developed using expert opinion to help identify these low acuity patients but have failed to show a benefit beyond regular decision-making. Predictive algorithms may be able to build accurate models, which can be used in the field to support the decision not to take a low-acuity patient to an ED. METHODS AND ANALYSIS: All patients in Yorkshire who were transported to the ED by ambulance between July 2019 and February 2020 will be included. Ambulance electronic patient care record (ePCR) clinical data will be used as candidate predictors for the model. These will then be linked to the corresponding ED record, which holds the outcome of a 'non-urgent attendance'. The estimated sample size is 52,958, with 4767 events and an EPP of 7.48. An XGBoost algorithm will be used for model development. Initially, a model will be derived using all the data and the apparent performance will be assessed. Then internal-external validation will use non-random nested cross-validation (CV) with test sets held out for each ED (spatial validation). After all models are created, a random-effects meta-analysis will be undertaken. This will pool performance measures such as goodness of fit, discrimination and calibration. It will also generate a prediction interval and measure heterogeneity between clusters. The performance of the full model will be updated with the pooled results. DISCUSSION: Creating a risk prediction model in this area will lead to further development of a clinical decision support tool that ensures every ambulance patient can get to the right place of care, first time. If this study is successful, it could help paramedics evaluate the benefit of transporting a patient to the ED before they leave the scene. It could also reduce congestion in the urgent and emergency care system.
trial registrationThis study was retrospectively registered with the ISRCTN: 12121281.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.